CN1277545A - 呼吸测试分析仪 - Google Patents
呼吸测试分析仪 Download PDFInfo
- Publication number
- CN1277545A CN1277545A CN98810490.3A CN98810490A CN1277545A CN 1277545 A CN1277545 A CN 1277545A CN 98810490 A CN98810490 A CN 98810490A CN 1277545 A CN1277545 A CN 1277545A
- Authority
- CN
- China
- Prior art keywords
- patient
- analyser
- sample
- breathing
- gas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 154
- 238000000034 method Methods 0.000 claims abstract description 48
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 167
- 230000000155 isotopic effect Effects 0.000 claims description 108
- 238000004458 analytical method Methods 0.000 claims description 83
- 239000000463 material Substances 0.000 claims description 76
- 210000000481 breast Anatomy 0.000 claims description 71
- 230000000241 respiratory effect Effects 0.000 claims description 25
- 238000010521 absorption reaction Methods 0.000 claims description 21
- 230000005855 radiation Effects 0.000 claims description 4
- 238000001228 spectrum Methods 0.000 claims description 2
- 238000010998 test method Methods 0.000 claims 4
- 239000007789 gas Substances 0.000 abstract description 67
- 230000008569 process Effects 0.000 abstract description 18
- 239000000126 substance Substances 0.000 abstract description 3
- 230000037406 food intake Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 99
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 26
- 238000005259 measurement Methods 0.000 description 22
- 239000004202 carbamide Substances 0.000 description 16
- 235000013877 carbamide Nutrition 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 210000003928 nasal cavity Anatomy 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 241000590002 Helicobacter pylori Species 0.000 description 7
- 239000006227 byproduct Substances 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 229940037467 helicobacter pylori Drugs 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 125000004429 atom Chemical group 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical group [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 3
- XSQUKJJJFZCRTK-OUBTZVSYSA-N Urea-13C Chemical compound N[13C](N)=O XSQUKJJJFZCRTK-OUBTZVSYSA-N 0.000 description 3
- 108010046334 Urease Proteins 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-OUBTZVSYSA-N Ammonia-15N Chemical compound [15NH3] QGZKDVFQNNGYKY-OUBTZVSYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical group [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019375 Helicobacter infections Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 229960000212 aminophenazone Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001722 carbon compounds Chemical class 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- XVAIDCNLVLTVFM-UHFFFAOYSA-N methacetin Chemical compound COC1=CC=C(NC(C)=O)C=C1 XVAIDCNLVLTVFM-UHFFFAOYSA-N 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-NJFSPNSNSA-N ((18)O)water Chemical compound [18OH2] XLYOFNOQVPJJNP-NJFSPNSNSA-N 0.000 description 1
- DMIUGJLERMOBNT-UHFFFAOYSA-N 4-amino-n-(3-methoxypyrazin-2-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound COC1=NC=CN=C1NS(=O)(=O)C1=CC=C(N)C=C1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 DMIUGJLERMOBNT-UHFFFAOYSA-N 0.000 description 1
- BKAJNAXTPSGJCU-UHFFFAOYSA-N 4-methyl-2-oxopentanoic acid Chemical compound CC(C)CC(=O)C(O)=O BKAJNAXTPSGJCU-UHFFFAOYSA-N 0.000 description 1
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 1
- NZBSJOHIMULERV-UHFFFAOYSA-N CN1C(=O)N(CC(C(O)=O)C(O)(CC(O)=O)C(O)=O)C(=O)C2=C1N=CN2C Chemical compound CN1C(=O)N(CC(C(O)=O)C(O)(CC(O)=O)C(O)=O)C(=O)C2=C1N=CN2C NZBSJOHIMULERV-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 101000601993 Homo sapiens Protocadherin gamma-C3 Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 206010065042 Immune reconstitution inflammatory syndrome Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 208000035467 Pancreatic insufficiency Diseases 0.000 description 1
- 102100037560 Protocadherin gamma-C3 Human genes 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 206010041969 Steatorrhoea Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-NJFSPNSNSA-N UREA C 14 Chemical compound N[14C](N)=O XSQUKJJJFZCRTK-NJFSPNSNSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000013102 re-test Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000001162 steatorrhea Diseases 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229960001947 tripalmitin Drugs 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
- A61B5/0836—Measuring rate of CO2 production
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3504—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing gases, e.g. multi-gas analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/0004—Gaseous mixtures, e.g. polluted air
- G01N33/0006—Calibrating gas analysers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7239—Details of waveform analysis using differentiation including higher order derivatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Medical Informatics (AREA)
- Pulmonology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Combustion & Propulsion (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Optical Measuring Cells (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
Claims (46)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL121751 | 1997-09-11 | ||
IL12175197A IL121751A (en) | 1997-09-11 | 1997-09-11 | Breath test analyzer |
IL121793A IL121793A (en) | 1997-09-17 | 1997-09-17 | Isotopic gas analyzer |
IL121793 | 1997-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1277545A true CN1277545A (zh) | 2000-12-20 |
Family
ID=26323508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98810490.3A Pending CN1277545A (zh) | 1997-09-11 | 1998-09-10 | 呼吸测试分析仪 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1018938B1 (zh) |
JP (1) | JP2001515745A (zh) |
CN (1) | CN1277545A (zh) |
AT (1) | ATE379989T1 (zh) |
AU (1) | AU9182698A (zh) |
DE (1) | DE69838812T2 (zh) |
ES (1) | ES2319344T3 (zh) |
WO (1) | WO1999012471A2 (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100373158C (zh) * | 2002-01-09 | 2008-03-05 | 费希尔控制国际公司 | 用于化学检测系统的诊断装置和方法 |
CN100402093C (zh) * | 2002-08-26 | 2008-07-16 | 马永健 | 用于医学呼气诊断的药物 |
CN100483108C (zh) * | 2000-09-25 | 2009-04-29 | 大塚制药株式会社 | 确定二氧化碳吸收剂的吸收能力的方法 |
CN101657710B (zh) * | 2007-10-29 | 2011-12-21 | 松下电器产业株式会社 | 呼气分析方法 |
CN103764026A (zh) * | 2011-04-14 | 2014-04-30 | 艾克萨伦茨生物科技有限公司 | 用于肝细胞癌的诊断、预后、监测和治疗的方法 |
CN107003298A (zh) * | 2014-11-27 | 2017-08-01 | 皇家飞利浦有限公司 | 尿液和粪便蒸汽的化学分析 |
CN108523845A (zh) * | 2018-04-13 | 2018-09-14 | 北京航空航天大学 | 便携式新陈代谢测量仪 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6656127B1 (en) | 1999-06-08 | 2003-12-02 | Oridion Breathid Ltd. | Breath test apparatus and methods |
US6969357B1 (en) | 1999-06-08 | 2005-11-29 | Oridion Breathid Ltd. | Gas analyzer calibration checking device |
NZ518740A (en) * | 1999-11-08 | 2004-04-30 | Univ Florida | Marker detection method and apparatus to monitor drug compliance |
CA2401011A1 (en) * | 2000-02-22 | 2001-08-30 | Paul E. Cranley | Personal computer breath analyzer for health-related behavior modification and method |
JP2006508334A (ja) * | 2002-06-28 | 2006-03-09 | オリディオン ブレシド リミティド | 胃腸障害の管理 |
ATE421283T1 (de) | 2003-10-31 | 2009-02-15 | Otsuka Pharma Co Ltd | Verfahren zur bestimmung der gasinjektionsmenge in der isotopen-gasanalyse und isotopen-gas- analysier- und messverfahren und gerät |
US8622920B2 (en) | 2005-11-11 | 2014-01-07 | Exalenz Bioscience Ltd. | Breath test device and method |
US8512258B2 (en) | 2005-11-11 | 2013-08-20 | Exalenz Bioscience Ltd. | Breath test device and method |
CN101903773B (zh) * | 2007-12-20 | 2013-11-06 | 艾罗克林有限公司 | 用于测试设备功能的方法 |
JP6581171B2 (ja) * | 2017-12-13 | 2019-09-25 | 学校法人昭和大学 | 微生物のスクリーニング方法及びスクリーニング装置 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE33493E (en) | 1985-08-21 | 1990-12-18 | General Motors Corporation | Method and apparatus for measuring stable isotopes |
US4684805A (en) | 1985-08-21 | 1987-08-04 | General Motors Corporation | Method and apparatus for measuring stable isotopes |
US4830010A (en) | 1986-04-04 | 1989-05-16 | Marshall Barry J | Methods for the diagnosis of gastrointestinal disorders |
IL90744A (en) * | 1989-06-25 | 1992-07-15 | Spegas Ind Ltd | Method and apparatus for gas analysis |
DE3932838C2 (de) | 1989-09-30 | 1996-03-07 | Hartmann & Braun Ag | Nichtdispersiver Infrarot-Gasanalysator |
US5317156A (en) | 1992-01-29 | 1994-05-31 | Sri International | Diagnostic tests using near-infrared laser absorption spectroscopy |
US5394236A (en) | 1992-02-03 | 1995-02-28 | Rutgers, The State University | Methods and apparatus for isotopic analysis |
EP0584897B1 (de) | 1992-07-22 | 1996-10-16 | MANNESMANN Aktiengesellschaft | Nichtdispersives Infrarotspektrometer |
US5533512A (en) * | 1994-03-18 | 1996-07-09 | Ohmeda Inc. | Method and apparatus for detection of venous air emboli |
CN1138978C (zh) | 1995-10-09 | 2004-02-18 | 大冢制药株式会社 | 测定同位素气体的光谱学方法及其仪器 |
-
1998
- 1998-09-10 ES ES98944192T patent/ES2319344T3/es not_active Expired - Lifetime
- 1998-09-10 DE DE69838812T patent/DE69838812T2/de not_active Expired - Lifetime
- 1998-09-10 CN CN98810490.3A patent/CN1277545A/zh active Pending
- 1998-09-10 EP EP98944192A patent/EP1018938B1/en not_active Expired - Lifetime
- 1998-09-10 AT AT98944192T patent/ATE379989T1/de not_active IP Right Cessation
- 1998-09-10 AU AU91826/98A patent/AU9182698A/en not_active Abandoned
- 1998-09-10 WO PCT/IL1998/000445 patent/WO1999012471A2/en active IP Right Grant
- 1998-09-10 JP JP2000510373A patent/JP2001515745A/ja active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100483108C (zh) * | 2000-09-25 | 2009-04-29 | 大塚制药株式会社 | 确定二氧化碳吸收剂的吸收能力的方法 |
CN100373158C (zh) * | 2002-01-09 | 2008-03-05 | 费希尔控制国际公司 | 用于化学检测系统的诊断装置和方法 |
CN100402093C (zh) * | 2002-08-26 | 2008-07-16 | 马永健 | 用于医学呼气诊断的药物 |
CN101657710B (zh) * | 2007-10-29 | 2011-12-21 | 松下电器产业株式会社 | 呼气分析方法 |
CN103764026A (zh) * | 2011-04-14 | 2014-04-30 | 艾克萨伦茨生物科技有限公司 | 用于肝细胞癌的诊断、预后、监测和治疗的方法 |
CN107003298A (zh) * | 2014-11-27 | 2017-08-01 | 皇家飞利浦有限公司 | 尿液和粪便蒸汽的化学分析 |
CN108523845A (zh) * | 2018-04-13 | 2018-09-14 | 北京航空航天大学 | 便携式新陈代谢测量仪 |
CN108523845B (zh) * | 2018-04-13 | 2020-07-28 | 北京航空航天大学 | 便携式新陈代谢测量仪 |
Also Published As
Publication number | Publication date |
---|---|
DE69838812D1 (de) | 2008-01-17 |
ES2319344T3 (es) | 2009-05-06 |
EP1018938B1 (en) | 2007-12-05 |
ATE379989T1 (de) | 2007-12-15 |
AU9182698A (en) | 1999-03-29 |
EP1018938A2 (en) | 2000-07-19 |
WO1999012471A2 (en) | 1999-03-18 |
JP2001515745A (ja) | 2001-09-25 |
DE69838812T2 (de) | 2008-11-27 |
WO1999012471A3 (en) | 1999-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6491643B2 (en) | Breath test analyzer | |
CN1277545A (zh) | 呼吸测试分析仪 | |
EP1480557B1 (en) | Breath collection system | |
Marshall et al. | A 20-minute breath test for helicobacter pylori. | |
Paschke et al. | Clinical applications of breath testing | |
USRE38728E1 (en) | Breath test analyzer | |
Vreman et al. | Semiportable electrochemical instrument for determining carbon monoxide in breath | |
US20050171449A1 (en) | Method and apparatus for detecting ammonia from exhaled breath | |
JP2005501233A (ja) | 分光呼気分析 | |
CN110290747B (zh) | 用于呼吸分析的方法和装置 | |
WO1998057145A1 (en) | System and method for detection of a biological condition | |
Hryniuk et al. | A preliminary investigation of exhaled breath from patients with celiac disease using selected ion flow tube mass spectrometry. | |
CN1678241A (zh) | 将静脉血值转换成动脉血值的方法、采用该方法的系统以及该系统的装置 | |
Wang et al. | Breath acetone analysis of diabetic dogs using a cavity ringdown breath analyzer | |
US10076268B1 (en) | Portable unit for metabolic analysis | |
CN108267480A (zh) | 一种呼氢肠胃功能与疾病检测系统及检测方法 | |
EP0253927A1 (en) | A breath test for measuring urease activity in the stomach using carbon isotope urea | |
Namjou et al. | The Breathmeter-A new laser device to analyze your health | |
Namjou et al. | Breath-analysis using mid-infrared tunable laser spectroscopy | |
US20220095923A1 (en) | System and apparatus for detecting diseases | |
CN206177813U (zh) | 一种光谱法检测幽门螺旋杆菌的装置 | |
Broide et al. | Evaluation of Exalenz Bioscience’s BreathID for Helicobacter pylori detection | |
CN106353272B (zh) | 智能呼气分子诊断系统的透射式光学检测装置 | |
IL121751A (en) | Breath test analyzer | |
CN114486836B (zh) | 飞沫/气溶胶暴露风险评价方法、装置、设备及存储介质 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: AOLAIDENGBULAI WEST GERMANY CO., LTD. Free format text: FORMER OWNER: ORIDION MEDICAL LTD. Effective date: 20030605 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20030605 Address after: Israel Jerusalem Applicant after: O Lydon Bly Sid Ltd Address before: Israel Jerusalem Applicant before: Oridion Medical Ltd. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1080711 Country of ref document: HK |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1033083 Country of ref document: HK |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |